checkAd
Centessa Pharmaceuticals Aktie
ISIN: US1523091007 · WKN: A3CQ72 · SYM: 260
3,400
 
EUR
-7,10 %
-0,260 EUR
Letzter Kurs 17.01.23 · Tradegate

Neueste Nachrichten

Bronstein, Gewirtz & Grossman, LLC, A Top Firm, Reminds Centessa Pharmaceuticals plc (CNTA) Investors of Class Action Deadline and Encourages Investors to Actively Participate
28.11.22 · Business Wire (engl.) · Centessa Pharmaceuticals
CENTESSA PHARMACEUTICALS 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess Of $100,000 of Deadline in Class Action Lawsuit Against Centessa Pharmaceuticals plc - CNTA
26.11.22 · Business Wire (engl.) · Centessa Pharmaceuticals
CENTESSA DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Centessa Pharmaceuticals Plc and Encourages Investors to Contact the Firm
26.11.22 · Business Wire (engl.) · Centessa Pharmaceuticals
Bronstein, Gewirtz & Grossman, LLC, A Top Firm, Notifies Centessa Pharmaceuticals plc (CNTA) Investors of Class Action and Encourages Investors to Actively Participate
13.10.22 · Business Wire (engl.) · Centessa Pharmaceuticals
INVESTOR NOTICE: Centessa Pharmaceuticals plc Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – CNTA
03.10.22 · Business Wire (engl.) · Centessa Pharmaceuticals
CENTESSA PHARMACEUTICALS SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Centessa Pharmaceuticals plc - CNTA
01.10.22 · Business Wire (engl.) · Centessa Pharmaceuticals
Centessa Pharmaceuticals plc Shareholder Update: Robbins LLP Reminds Investors of Class Action Against Centessa Pharmaceuticals plc (CNTA)
30.09.22 · Business Wire (engl.) · Centessa Pharmaceuticals
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Centessa Pharmaceuticals plc with Losses of $100,000 to Contact the Firm
30.09.22 · Business Wire (engl.) · Centessa Pharmaceuticals
CENTESSA ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Centessa Pharmaceuticals Plc and Encourages Investors to Contact the Firm
30.09.22 · Business Wire (engl.) · Centessa Pharmaceuticals
Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Centessa Pharmaceuticals plc (CNTA)
29.09.22 · Business Wire (engl.) · Centessa Pharmaceuticals
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Centessa Pharmaceuticals plc with Losses of $100,000 to Contact the Firm
29.09.22 · Business Wire (engl.) · Centessa Pharmaceuticals
INVESTIGATION NOTICE: The Schall Law Firm Encourages Investors in Centessa Pharmaceuticals plc with Losses of $100,000 to Contact the Firm
15.08.22 · Business Wire (engl.) · Centessa Pharmaceuticals